Plan B Ruling Sets A Precedent That Could Give FDA Pause
This article was originally published in The Tan Sheet
Executive Summary
The court ruling overturning FDA's denial of a citizen petition concerning access to the emergency contraceptive Plan B puts the administration in a pickle: to appeal the decision, or comply and allow a precedent that could trouble all federal agencies
You may also be interested in...
Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle
HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.
Teva Plan B OTC Application Fails Political Test After Clearing FDA Hurdle
HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.
Plan B Lightning May Strike Again: Complying Will Not End Political Storm
Perpetual political lightning rod - and emergency contraceptive - Plan B has another chance to draw strikes to FDA as the agency has chosen to comply with a court ruling ordering it to reconsider whether the drug should be available in a truly over-the counter setting